NuVasive Company Profile (NASDAQ:NUVA)

About NuVasive

NuVasive logoNuvasive, Inc. is a medical device company in the spine market. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine. The Company offers two product lines: spine surgery products and biologics. The Company's spine surgery products line offerings include thoracolumbar product offerings, cervical product offerings, Intra-Operative Monitoring (IOM) services and disposables, which are used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The Company's biologics product line offerings includes allograft (donated human tissue), FormaGraft (a collagen synthetic product), Osteocel Plus and Osteocel Pro (each an allograft cellular matrix containing viable mesenchymal stem cells (MSCs)), and AttraX (a synthetic bone graft material), all of which are used to aid the spinal fusion or bone healing process.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: NUVA
  • CUSIP: 67070410
Key Metrics:
  • Previous Close: $63.39
  • 50 Day Moving Average: $62.37
  • 200 Day Moving Average: $53.67
  • Trailing P/E Ratio: 66.46
  • Foreward P/E Ratio: 30.95
  • P/E Growth: 2.39
  • Market Cap: $3.22B
  • Outstanding Shares: 50,214,000
  • Beta: 0.97
Additional Links:
Companies Related to NuVasive:

Analyst Ratings

Consensus Ratings for NuVasive (NASDAQ:NUVA) (?)
Ratings Breakdown: 3 Hold Ratings, 10 Buy Ratings
Consensus Rating:Buy (Score: 2.77)
Consensus Price Target: $63.92 (0.24% downside)

Analysts' Ratings History for NuVasive (NASDAQ:NUVA)
DateFirmActionRatingPrice TargetDetails
8/3/2016Jefferies GroupReiterated RatingBuyView Rating Details
7/27/2016Barclays PLCBoost Price TargetOverweight$63.00 -> $71.00View Rating Details
7/27/2016Brean CapitalBoost Price TargetBuy$60.00 -> $70.00View Rating Details
7/13/2016JPMorgan Chase & Co.UpgradeNeutral -> Overweight$55.00 -> $74.00View Rating Details
6/6/2016Canaccord GenuityReiterated RatingBuyView Rating Details
6/7/2016Morgan StanleyReiterated RatingHold$57.00View Rating Details
6/3/2016Piper Jaffray Cos.Reiterated RatingOverweight$58.00View Rating Details
5/10/2016Leerink SwannReiterated RatingBuy$65.00View Rating Details
4/27/2016Needham & Company LLCReiterated RatingHoldView Rating Details
4/27/2016Cowen and CompanyReiterated RatingBuy$52.00 -> $63.00View Rating Details
12/11/2015Bank of America Corp.UpgradeUnderperform -> Neutral$56.00View Rating Details
10/6/2015BMO Capital MarketsUpgradeMarket Perform -> Outperform$52.00 -> $64.00View Rating Details
10/5/2015Royal Bank Of CanadaReiterated RatingOutperform$58.00View Rating Details
7/29/2015Northland SecuritiesUpgradeMarket Perform -> Outperform$48.00 -> $68.00View Rating Details
6/3/2015Goldman Sachs Group Inc.DowngradeBuy -> Neutral$52.00View Rating Details
1/13/2015WallachBeth CapitalBoost Price TargetBuy$49.00 -> $55.00View Rating Details
1/13/2015Robert W. BairdBoost Price TargetOutperform$50.00 -> $55.00View Rating Details
1/13/2015Summer StreetDowngradeBuy -> NeutralView Rating Details
11/17/2014Wells Fargo & Co.UpgradeMarket Perform -> OutperformView Rating Details
(Data available from 8/27/2014 forward)


Earnings History for NuVasive (NASDAQ:NUVA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/26/2016Q216$0.36$0.40$232.86 million$236.50 millionViewListenView Earnings Details
4/26/2016Q116$0.27$0.31$205.54 million$215.10 millionViewListenView Earnings Details
2/11/2016Q415$0.31$0.35$215.08 million$215.30 millionViewListenView Earnings Details
10/27/2015Q315$0.27$0.35$200.21 million$200.50 millionViewListenView Earnings Details
7/28/2015Q215$0.25$0.31$200.71 million$202.91 millionViewListenView Earnings Details
5/4/2015Q115$0.21$0.30$189.30 million$192.40 millionViewListenView Earnings Details
2/24/2015Q4$0.37$0.39$201.40 million$204.30 millionViewListenView Earnings Details
10/30/2014Q314$0.25$0.19$179.30 million$189.90 millionViewListenView Earnings Details
7/29/2014Q214$0.25$0.28$177.50 million$190.70 millionViewListenView Earnings Details
4/29/2014Q114$0.23$0.29$171.30 million$177.50 millionViewListenView Earnings Details
3/3/2014Q413$0.32$0.37$181.24 million$190.80 millionViewListenView Earnings Details
10/29/2013Q313$0.24$0.39$158.30 million$169.20 millionViewListenView Earnings Details
7/30/2013Q2 2013$0.23$0.20$161.67 million$165.70 millionViewListenView Earnings Details
4/30/2013Q1 2013$0.22$0.26$157.34 million$159.50 millionViewListenView Earnings Details
2/26/2013Q4 2012$0.21$0.34$156.35 million$165.80 millionViewListenView Earnings Details
10/24/2012$0.21$0.23ViewN/AView Earnings Details
7/25/2012$0.23$0.27ViewN/AView Earnings Details
4/30/2012$0.18$0.20ViewN/AView Earnings Details
2/22/2012$0.22$0.27ViewN/AView Earnings Details
10/27/2011$0.24$0.26ViewN/AView Earnings Details
7/25/2011$0.28$0.30ViewN/AView Earnings Details
5/5/2011$0.19$0.24ViewN/AView Earnings Details
2/23/2011$0.42$0.46ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for NuVasive (NASDAQ:NUVA)
Current Year EPS Consensus Estimate: $1.65 EPS
Next Year EPS Consensus Estimate: $2.07 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.25$0.32$0.29
Q2 20166$0.33$0.39$0.37
Q3 20163$0.39$0.40$0.40
Q4 20163$0.42$0.52$0.48
Q1 20172$0.39$0.39$0.39
Q2 20172$0.48$0.50$0.49
Q3 20172$0.51$0.55$0.53
Q4 20172$0.65$0.66$0.66
(Data provided by Zacks Investment Research)


Dividend History for NuVasive (NASDAQ:NUVA)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for NuVasive (NASDAQ:NUVA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/23/2016Jason HannonEVPSell2,625$64.80$170,100.00View SEC Filing  
8/2/2016Jason HannonEVPSell11,184$62.70$701,236.80View SEC Filing  
8/2/2016Lesley H. HoweDirectorSell3,602$62.44$224,908.88View SEC Filing  
7/20/2016Jason HannonEVPSell2,920$62.80$183,376.00View SEC Filing  
6/16/2016Jason HannonEVPSell14,534$57.57$836,722.38View SEC Filing  
1/6/2016Patrick MilesCOOSell10,723$54.03$579,363.69View SEC Filing  
12/16/2015Patrick MilesCOOSell9,127$52.56$479,715.12View SEC Filing  
12/7/2015Quentin S BlackfordCFOSell15,000$51.10$766,500.00View SEC Filing  
12/3/2015Patrick MilesCOOSell5,873$52.51$308,391.23View SEC Filing  
11/2/2015Patrick MilesCOOSell15,000$48.12$721,800.00View SEC Filing  
10/5/2015Matthew LinkinsiderSell1,714$50.72$86,934.08View SEC Filing  
10/3/2015Quentin S BlackfordCFOSell5,000$36.30$181,500.00View SEC Filing  
10/1/2015Patrick MilesCOOSell15,000$48.10$721,500.00View SEC Filing  
9/8/2015Russell PowersEVPSell5,806$51.64$299,821.84View SEC Filing  
9/2/2015Jason HannonEVPSell11,962$52.02$622,263.24View SEC Filing  
9/1/2015Patrick MilesCOOSell15,000$52.03$780,450.00View SEC Filing  
8/31/2015Patrick MilesCOOSell15,000$53.34$800,100.00View SEC Filing  
7/20/2015Jason HannonEVPSell15,000$49.60$744,000.00View SEC Filing  
6/15/2015Gregory T LucierCEOBuy4,491$49.49$222,259.59View SEC Filing  
6/12/2015Gregory T LucierCEOBuy8,000$50.10$400,800.00View SEC Filing  
6/10/2015Gregory T LucierCEOBuy10,000$49.10$491,000.00View SEC Filing  
6/8/2015Gregory T LucierCEOBuy10,000$49.26$492,600.00View SEC Filing  
6/4/2015Gregory T LucierCEOBuy10,000$49.71$497,100.00View SEC Filing  
6/2/2015Gregory T LucierCEOBuy8,000$49.96$399,680.00View SEC Filing  
6/2/2015Patrick MilesCOOSell4,194$49.47$207,477.18View SEC Filing  
5/29/2015Jack R BlairDirectorSell3,703$50.16$185,742.48View SEC Filing  
5/28/2015Gregory T LucierCEOBuy34,000$49.25$1,674,500.00View SEC Filing  
5/28/2015Russell PowersEVPSell8,042$49.00$394,058.00View SEC Filing  
5/19/2015Patrick MilesCOOSell15,000$47.52$712,800.00View SEC Filing  
5/1/2015Russell PowersEVPSell11,881$45.21$537,140.01View SEC Filing  
4/24/2015Russell PowersEVPSell3,888$44.07$171,344.16View SEC Filing  
3/13/2015Patrick MilesCOOSell7,920$45.52$360,518.40View SEC Filing  
3/9/2015Alexis V LukianovCEOSell5,313$44.82$238,128.66View SEC Filing  
3/3/2015Matthew LinkInsiderSell7,500$44.46$333,450.00View SEC Filing  
3/2/2015Jason HannonEVPSell5,085$45.06$229,130.10View SEC Filing  
2/9/2015Alexis V LukianovCEOSell5,454$46.10$251,429.40View SEC Filing  
2/5/2015Matthew LinkInsiderSell4,078$45.77$186,650.06View SEC Filing  
2/3/2015Patrick MilesCOOSell15,000$45.53$682,950.00View SEC Filing  
1/28/2015Keith ValentineCOOSell6,970$46.96$327,311.20View SEC Filing  
1/12/2015Alexis V LukianovCEOSell7,452$49.69$370,289.88View SEC Filing  
1/5/2015Jason HannonEVPSell12,117$46.82$567,317.94View SEC Filing  
1/5/2015Patrick MilesInsiderSell15,000$46.61$699,150.00View SEC Filing  
12/30/2014Jason HannonEVPSell15,000$47.63$714,450.00View SEC Filing  
12/29/2014Jason HannonEVPSell3,146$47.57$149,655.22View SEC Filing  
12/24/2014Patrick MilesInsiderSell15,000$47.52$712,800.00View SEC Filing  
12/19/2014Keith ValentineCOOSell5,893$47.78$281,567.54View SEC Filing  
12/1/2014Keith ValentineCOOSell2,500$43.66$109,150.00View SEC Filing  
11/19/2014Keith ValentineCOOSell5,582$43.32$241,812.24View SEC Filing  
11/19/2014Quentin S BlackfordCFOSell7,698$43.41$334,170.18View SEC Filing  
11/7/2014Alexis V LukianovCEOSell25,000$41.40$1,035,000.00View SEC Filing  
11/3/2014Keith ValentineCOOSell2,500$40.61$101,525.00View SEC Filing  
10/2/2014Keith ValentineCOOSell2,500$35.00$87,500.00View SEC Filing  
9/2/2014Keith ValentineCOOSell2,500$35.14$87,850.00View SEC Filing  
8/1/2014Keith ValentineCOOSell2,500$37.11$92,775.00View SEC Filing  
8/1/2014Michael LambertCFOSell4,010$37.11$148,811.10View SEC Filing  
7/30/2014Jason HannonEVPSell5,000$39.00$195,000.00View SEC Filing  
7/10/2014Russell PowersEVPSell3,200$33.43$106,976.00View SEC Filing  
7/1/2014Keith ValentineCOOSell2,500$35.65$89,125.00View SEC Filing  
7/1/2014Michael LambertCFOSell23,225$35.48$824,023.00View SEC Filing  
6/20/2014Keith ValentineCOOSell5,000$35.00$175,000.00View SEC Filing  
6/20/2014Russell PowersEVPSell9,526$35.00$333,410.00View SEC Filing  
5/5/2014Robert HuntDirectorSell20,000$34.25$685,000.00View SEC Filing  
5/2/2014Michael LambertCFOSell13,096$33.07$433,084.72View SEC Filing  
4/1/2014Keith ValentineCOOSell2,500$38.41$96,025.00View SEC Filing  
3/11/2014Peter FarrellDirectorSell48,000$36.88$1,770,240.00View SEC Filing  
1/21/2014Jason HannonEVPSell10,095$36.60$369,477.00View SEC Filing  
1/16/2014Keith ValentineCOOSell20,000$37.96$759,200.00View SEC Filing  
1/7/2014Alexis LukianovCEOSell34,217$34.29$1,173,300.93View SEC Filing  
1/7/2014Craig HunsakerSVPSell4,980$35.00$174,300.00View SEC Filing  
12/30/2013Craig HunsakerSVPSell4,275$32.10$137,227.50View SEC Filing  
12/23/2013Michael LambertCFOSell17,091$32.49$555,286.59View SEC Filing  
11/7/2013Alexis LukianovCEOSell5,000$31.45$157,250.00View SEC Filing  
10/30/2013Jason HannonEVPSell2,334$28.90$67,452.60View SEC Filing  
10/30/2013Patrick MilesInsiderSell21,223$31.10$660,035.30View SEC Filing  
10/28/2013Patrick MilesInsiderSell7,331$25.72$188,553.32View SEC Filing  
10/21/2013Russell PowersVPSell12,500$25.39$317,375.00View SEC Filing  
10/11/2013Jason HannonEVPSell1,000$26.00$26,000.00View SEC Filing  
10/7/2013Jason HannonEVPSell8,705$23.99$208,832.95View SEC Filing  
10/7/2013Michael LambertCFOSell15,442$24.04$371,225.68View SEC Filing  
8/6/2013Richard Treharne IIIDirectorBuy2,000$23.26$46,520.00View SEC Filing  
7/12/2013Craig E HunsakerSVPSell2,000$27.00$54,000.00View SEC Filing  
7/8/2013Alexis V LukianovCEOSell5,000$25.74$128,700.00View SEC Filing  
7/1/2013Keith ValentineCOOSell1,698$25.00$42,450.00View SEC Filing  
5/13/2013Alexis V LukianovCEOSell7,500$22.71$170,325.00View SEC Filing  
5/8/2013Peter Michael LeddyDirectorBuy2,400$22.24$53,376.00View SEC Filing  
5/7/2013Alexis V LukianovCEOSell12,500$22.11$276,375.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for NuVasive (NASDAQ:NUVA)
DateHeadline logoUptrend Call Working As NuVasive Stock Rises 45.1% (NUVA) (NASDAQ:NUVA) - August 26 at 6:17 PM logoBioTelemetry Forms Partnership with Bloomlife, Stock Down (NASDAQ:NUVA) - August 24 at 9:40 AM
News IconStock Trading Above Moving Averages: NuVasive, Inc. (NASDAQ:NUVA) - Post News (NASDAQ:NUVA) - August 22 at 6:31 PM
News IconStock Gaining Over the Past Six Months: NuVasive, Inc. (NASDAQ:NUVA) - Post News (NASDAQ:NUVA) - August 22 at 11:06 AM logoAkers Biosciences OxiCheck Study Results Positive, Stock Up (NASDAQ:NUVA) - August 22 at 11:06 AM logoShares of NUVA Up 44.8% Since Uptrend Call on Shares (NASDAQ:NUVA) - August 19 at 9:35 AM logoNuVasive Up 44.1% Since SmarTrend Uptrend Call (NUVA) (NASDAQ:NUVA) - August 11 at 7:02 PM logoAlere (ALR) Reader Attains CE Mark, Submits Delayed 10K (NASDAQ:NUVA) - August 11 at 9:47 AM
News IconNuVasive wins CMS add-on payment for Magec growth mod system (NASDAQ:NUVA) - August 6 at 9:23 AM logoNuVasive Inc. (NUVA) Hits New 52-week High During August 01 Session - (NASDAQ:NUVA) - August 4 at 6:57 PM logoNuVasive, Inc. Is Taking Market Share and the CEO Isn't Afraid to Tout It - Motley Fool (NASDAQ:NUVA) - August 4 at 6:57 PM logoOpen house for Dayton-area company hiring 200 (NASDAQ:NUVA) - August 4 at 6:57 PM logoETF’s with exposure to NuVasive, Inc. : August 4, 2016 (NASDAQ:NUVA) - August 4 at 6:57 PM logoNuVasive Secures CMS Add-On Payment for Innovative MAGEC System (NASDAQ:NUVA) - August 4 at 9:43 AM logoNuVasive, Inc. :NUVA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 (NASDAQ:NUVA) - August 3 at 6:54 PM logoNuVasive, Inc. Is Taking Market Share and the CEO Isn't Afraid to Tout It (NASDAQ:NUVA) - August 3 at 6:03 PM logoNuVasive Inc. (NUVA) Hits New 52-week High During August 01 Session (NASDAQ:NUVA) - August 3 at 9:48 AM
News IconMichael D. O’Halleran and Patrick S. Miles Elected to NuVasive Board of Directors (NASDAQ:NUVA) - August 1 at 6:17 PM logoMichael D. O'Halleran and Patrick S. Miles Elected to NuVasive Board of Directors (NASDAQ:NUVA) - August 1 at 7:21 AM logoNUVASIVE INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; (NASDAQ:NUVA) - August 1 at 7:04 AM logoNUVASIVE INC Financials (NASDAQ:NUVA) - July 30 at 1:04 PM logoWhere Will a Healthy Zimmer Biomet Turn Next for Acquisitions? (NASDAQ:NUVA) - July 29 at 6:20 PM logoNuVasive, Inc. Reveals 31% Gain In Q2 Profit - Nasdaq (NASDAQ:NUVA) - July 28 at 6:48 PM
News IconIndirect Patent Infringement Can Be Based on Willful Blindness and Circumstantial Evidence (NASDAQ:NUVA) - July 28 at 9:46 AM
News IconNuVasive's Healthy Q2 Earnings Beat Wall Street Expectations (NASDAQ:NUVA) - July 27 at 6:55 PM logoNuVasive (NUVA) Beats on Q2 Earnings, Raises FY16 View (NASDAQ:NUVA) - July 27 at 3:27 PM logoHow These Healthcare Stocks are Performing? -- Antares Pharma, Insulet, Globus Medical, and NuVasive (NASDAQ:NUVA) - July 27 at 9:35 AM logoEdited Transcript of NUVA earnings conference call or presentation 26-Jul-16 8:30pm GMT (NASDAQ:NUVA) - July 27 at 2:59 AM logoNUVASIVE INC : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) (NASDAQ:NUVA) - July 26 at 6:51 PM logoNuVasive, Inc. Reveals 31% Gain In Q2 Profit (NASDAQ:NUVA) - July 26 at 6:51 PM logoNuVasive Reports Second Quarter 2016 Financial Results (NASDAQ:NUVA) - July 26 at 6:51 PM logoNuVasive tops Street 2Q forecasts (NASDAQ:NUVA) - July 26 at 4:51 PM logoQ2 2016 NuVasive Inc Earnings Release - After Market Close (NASDAQ:NUVA) - July 26 at 7:07 AM
News IconInduced Infringement Becomes More Difficult To Defend (NASDAQ:NUVA) - July 25 at 6:40 PM logoCan NuVasive, Inc. (NASDAQ:NUVA) Keep Up with Analyst Expectations? - Investor Newswire (NASDAQ:NUVA) - July 24 at 10:43 AM
News IconNuVasive, Inc. on Focus After Trading At 52-Week Highs - Consumer Eagle (NASDAQ:NUVA) - July 22 at 6:23 PM
News IconNuVasive, Inc. (NASDAQ:NUVA): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:NUVA) - July 22 at 6:23 PM logoHill-Rom Holdings Inc versus NuVasive Inc Head to Head Compare - CML News (NASDAQ:NUVA) - July 22 at 6:23 PM
News IconEarnings Watchlist: NuVasive, Inc. (NASDAQ:NUVA), The Rubicon Project, Inc. (NYSE:RUBI), Emerge Energy Services ... - Engelwood Daily (NASDAQ:NUVA) - July 22 at 6:23 PM
News IconStock to Follow: Earnings Check and Target Projections for NuVasive, Inc. (NASDAQ:NUVA) - TGP (NASDAQ:NUVA) - July 22 at 6:23 PM logoNuVasive Inc. (NUVA) Hits New 52-week High During July 20 Session - (NASDAQ:NUVA) - July 22 at 6:23 PM logoNuVasive Inc versus Insulet Corporation Head to Head Compare - CML News (NASDAQ:NUVA) - July 22 at 6:23 PM
News IconAttention Grasping Stock With Upward Momentum: NuVasive, Inc. (NASDAQ:NUVA) - TGP (NASDAQ:NUVA) - July 22 at 6:23 PM
News IconInvestor News: NuVasive, Inc. (NASDAQ:NUVA) under Investigation - GroundReport (NASDAQ:NUVA) - July 22 at 6:23 PM logoNuVasive Inc. (NUVA) Hits New 52-week High During July 20 Session (NASDAQ:NUVA) - July 22 at 9:31 AM
News IconAging Global Population Pushes Demand for Orthopedic Devices Market (NASDAQ:NUVA) - July 20 at 7:19 PM featured highlights: Select Comfort, Select Medical Holdings, WEX, NuVasive and Post Holdings (NASDAQ:NUVA) - July 20 at 9:30 AM logoETF’s with exposure to NuVasive, Inc. : July 19, 2016 (NASDAQ:NUVA) - July 19 at 12:55 PM logo5 Best Stocks with Upgraded Broker Ratings (NASDAQ:NUVA) - July 19 at 9:41 AM logoNuVasive, Inc. (NASDAQ:NUVA) Expected To Post Sales Of $1293.8 - Investor Newswire (NASDAQ:NUVA) - July 19 at 8:52 AM


NuVasive (NASDAQ:NUVA) Chart for Saturday, August, 27, 2016

Last Updated on 8/27/2016 by Staff